Do not restrict Indian pharmaceutical industry, says Elton John
London, Feb 10: Singer Elton John is urging officials to stop plans to restrict India's pharmaceutical industry, branding the proposals an "attack on the health of the world's poor". Read Full Story

Aspirin 'may thwart DVT and PE in joint replacement patients'
Washington, Feb 8 : Following a total joint replacement, anticoagulation drugs can prevent Deep Vein Thrombosis (DVT) or pulmonary embolism (PE), a new study has revealed. Read Full Story

Dr Peter Nightingale appointed as President of Acoris Research
Pune, Feb 7 : Hikal Ltd, the preferred long-term outsourcing partner for leading global life sciences and fine chemical companies, announced the appointment of Dr Peter Nightingale as the President of its 100 percent contract research subsidiary, Acoris Research Ltd in Pune. Read Full Story

Fortis launches comprehensive spine care programme
Kolkata, Feb 7 : To make eastern India free from back and neck pains and related problems, Fortis Hospitals Kolkata launched a comprehensive spine-care programme here today. Read Full Story

Celon Labs launches Healon
Hyderabad, Feb 6 : Hyderabad-based Celon Laboratories Limited, a fully integrated specialty biopharmaceutical company, today announced the launch of its fifth division 'Healon'. Read Full Story

NATCONPH 2012 kicks off in Kolkata
Kolkata, Feb 3 : The National Conference on Pharmaceutical Technology (NATCONPH 2012) got underway in Kolkata on Friday. Read Full Story

Dr Reddys Lab consolidated net up by 87.80 pc
Mumbai, Feb 3 : Dr Reddy's Laboratories, an integrated global pharmaceutical company, today said its consolidated net profit surged by 87.80 per cent to Rs 512.96 crore for the quarter ended December 31, 2011 as compared to Rs 273.14 crore for the quarter ended December 31, 2010. Read Full Story

Medicall to showcase latest in medical equipment
Ahmedabad, Feb 1 : The eighth edition of three-day 'Medicall 2012', an exhibition of medical equipment and hospitalwares, will be on display from February 3 at university grounds here. Read Full Story

HIV drug now available as oral powder for children
New Delhi, Jan 29 : The HIV drug Viread will now be available in powder form for HIV positive children after its approval by the US Food and Drug Administration (FDA), a bio-pharmaceutical company said Sunday. The move is expected to benefit millions of HIV positive children. Read Full Story

Ranbaxy ordered to improve India, US plants
By Arun Kumar, Washington, Jan 26: US drug regulators have sought a "groundbreaking" injunction against Ranbaxy Laboratories to force the Indian drug major to correct long-standing violations at four of its manufacturing facilities. Read Full Story

Pharma company Granules India's net profit up 42 percent
Hyderabad, Jan 24 : Granules India Ltd., a fast growing pharmaceutical manufacturing company, has posted growth of 42 percent in its net profit for the third quarter ended Dec 31. Read Full Story

Merck to sponsor Tagore award
Kolkata, Jan 17 : German pharmaceutical company Merck will sponsor the Merck-Tagore Cultural award to honour the work and life of the first non-European Nobel laureate Rabindranath Tagore. Read Full Story

Jammu institute develops breast cancer drug
Jammu, Jan 17 : The Indian Institute of Integrative Medicine (IIIM), Jammu, has developed a drug for the treatment of hypertension and breast cancer, an official said. Read Full Story

Wockhardt gets US regulator nod for rhinitis nasal spray
New Delhi, Jan 10 : Pharmaceutical firm Wockhardt today announced that it has received a final approval from the US regulator for marketing a drug, used for treatment of allergic rhinitis. Read Full Story

Zydus Cadila, Microbix ink strategic pact to market Urokinase
Mumbai, Jan 9 : Pharam Major Zydus Cadila and Microbix Biosystems, a biotechnology company commercializing in novel technologies, announced that they have signed a Letter of Intent (LoI) to market Thrombolytic drug, Urokinase in the North American markets. Read Full Story

Forbes picks BMS as Best Big Drug Company
New Delhi, Jan 4 : Bristol Myers Squibb (BMS),a global biopharmaceutical company, has ranked as 'The Best Big Drug Company Of 2011' in the latest issue of Forbes. Read Full Story

Goose launches Artwork Manager for pharma industry
Hyderabad, Jan 3: City-based software company Goose Tuesday said it has introduced its Artwork Manager solution that has advanced proof-reading capabilities for pharmaceutical packaging. Read Full Story

Medplus launches 'Medplus Beauty.com'
Hyderabad, Dec 22 : A concept that is aimed at delivering convenience, excitement and value for money for customers, Medplus Beauty.com, a unique online beauty store, was launched today amidst a live demonstration of its features. Read Full Story

Ranbaxy settles issue with US health regulator
Gurgaon, Dec 21 : Drug firm Ranbaxy Wednesday said it
has inked an agreement with the US health regulator for lifting a ban on import of drugs from its two facilities in India. Read Full Story

Zydus Cadila buys out Biochem
Ahmedabad, Dec 21: Pharmaceutical major Zydus Cadila Wednesday said it has bought out the Mumbai-based Biochem to boost its formulations business. Read Full Story

Zydus acquires 100 Percent stake in Mumbai-based Biochem
Mumbai, Dec 21: Pharma Major Zydus Cadila has acquired 100 percent stake in Biochem, one of the top 40 pharma companies in India. Read Full Story

Ranbaxy announces settlement with USFDA
New Delhi, Dec 21 :Pharmaceutical firm Ranbaxy Laboratories today said it has signed an agreement with the US Food and Drug Administration (USFDA) to lift a ban on the import of drugs from certain manufacturing plants in India and will pay up to 500 million dollar to settle a case lodged by the Department of Justice. Read Full Story

Ozone collaborates with Japanese company
Mumbai, Dec 16: Ozone Pharmaceuticals Limited, one of India's fastest growing Pharma companies, has entered into collaboration with a Japanese company 'Koboyashi Pharmaceutical Company Limited' to bring about a series of Air Activated Heat Packs for therapeutic relief. Read Full Story

Abbott releases Citizenship Report in India
Kolkata, Dec 16 : Abbott, India's leading pharmaceutical company, on Thursday announced the release of its 2011 Citizenship Report for India. Read Full Story

Sun Pharma gets USFDA nod for generic Ultram ER tablets
Mumbai, Dec 12: Pharma major, Sun Pharmaceutical Industries today said its US subsidiary has received US Food and Drug Administration's (USFDA) approval for its Abbreviated New Drug Application (ANDA) to market a generic version of UltramĀ® ER, Tramadol hydrochloride extended release tablets. Read Full Story

Lupin gets USFDA nod to market Duloxetine Hydrochloride in US
New Delhi, Dec 9: Pharmaceutical firm Lupin Ltd today announced that it has received approval from the US Food and Drug Administration (US FDA) to market Duloxetine Hydrochloride capsules in the US market. Read Full Story

New drug wipes out deadliest malaria parasite by starving it to death
Washington, Dec 8 : A newly developed anti-malarial agent clears infections caused by the malaria parasite most lethal to humans - by literally starving the parasites to death. Read Full Story

Fortis launches network of stand-alone dialysis centres
New Delhi, Dec 8: Fortis Healthcare (India) Ltd today announced the launch of Renkare, a chain of stand-alone dialysis centres, to meet the rising demand for quality dialysis. Read Full Story

Ozone collaborates with Japanese company Koboyashi
New Delhi, Dec 7: Ozone Pharmaceuticals Ltd., one of India's fastest growing pharma companies, has entered into pain management therapy in a big way. Read Full Story

Ranbaxy launches generic version of 'Caduet' in US
New Delhi, Dec 6 : Ranbaxy Pharmaceuticals today announced that it has launched an authorised generic version of Caduet in the US market. Read Full Story

Popular painkillers can turn into real killers
Sydney, Dec 2 : Paracetamol, one of the most popular painkillers, could cause fatal liver damage and even death if taken in large doses for uninterrupted periods, according to new research. Read Full Story

Lupin gets USFDA nod for generic Solodyn tablets
Mumbai, Dec 2 : Pharma major, Lupin today announced that its subsidiary, Lupin Pharmaceuticals has received final approval for its Minocycline hydrochloride extended release tablets of 45 mg, 55 mg, 90 mg and 135 mg strengths. Read Full Story

Ranbaxy approved to make first generic version of Lipitor
By Arun Kumar, Washington, Dec 1: India's largest maker of generic drugs, Ranbaxy Laboratories Ltd has won US approval to sell a generic version of the world's top-selling cholesterol lowering drug Lipitor hours after it lost US patent protection. Read Full Story

Ranbaxy gets US FDA not for 'Atorvastatin'
New Delhi, Dec 1 : Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Ltd, today announced that it has received final approval from the US Food and Drug Administration (FDA) to manufacture and market Atorvastatin and has launched the product in the US market. Read Full Story

BioAsia, Institute of Life Science join hands to promote innovaion
Hyderabad, Nov 29: The Institute of Life Sciences (ILS), has partnered with the Federation of Asian Biotech Associations (FABA) to scrutinise and recognise innovations through the BioAsia Innovation award and BioAsia Young Minds Award 2012. Read Full Story

Concerned over possible hike in medicine prices: Jena
New Delhi, Nov 29: The government Tuesday expressed its concern over a likely increase in prices of medicines by international companies which are eyeing Indian firms after being allowed investment up to 100 percent of capital in the sector. Read Full Story

Glenmark arm gets tentative USFDA approval for Montelokast
Mumbai, Nov 28 : Pharma Major Glenmark Pharmaceuticals today said that its United State Subsidiary, Glenmark Generics, USA, has received tentative approval for Montelukast Sodium 10 mg tablets, from United States Food and Drug Administration (U.S. FDA), their generic version of Singulair tablets. Read Full Story

HONLEA to assist in combating illicit drug production
New Delhi, Nov 21: The 35th Meeting of Heads of National Drug Law Enforcement Agencies (HONLEA), Asia and Pacific Region would assist the heads of National Drug Law Enforcement Agencies in the region in their efforts to combat illicit drug production and trafficking more effectively and to improve coordination of their action at the sub regional and regional levels. Read Full Story

Venus Remedies gets UK, NZ nod to market Meropenem
Chandigarh, Nov 15: Venus Remedies, a leading research based global pharmaceutical company, has received approval for Market Authorisation from MHRA (UK) via DCP route (which covers Ireland, Poland, Slovenia, Netherlands, Finland, Austria, Slovakia, Denmark, Germany, Sweden, France and Italy also) for its generic broad spectrum injectable antibiotic carbapenem. Read Full Story

Venus Remedies Gets Market Authorisation For Meropenem
Mumbai, Nov 15 : Mid-Sized Drugmaker Venus Remedies Ltd has said it had obtained approval for Market Authorization (MA) from the Modern Humanities Research Association (MHRA), UK, via DCP route, covering Ireland, Poland, Slovenia, Netherlands, Finland, Austria, Slovakia, Denmark, Germany, Sweden, France and Italy, for its generic broad spectrum injectable antibiotic carbapenem. Read Full Story

'Poor, illiterate' Indians becoming 'guinea pigs' for Western drugs firms' trials
London, Nov 14 : Pharmaceutical companies in the West have seized on developing countries like India over the past five years as a testing ground for drugs, where the research costs for lucrative products to be sold in the Western nations are very low. Read Full Story

Strides Arcolab gets US approval for Carboplatin injection
Mumbai, Nov 11 : Onco Therapies Limited, a wholly owned subsidiary of Strides Arcolab Limited (Strides) on Friday announced that it has received US FDA approval for Carboplatin Injection 10 mg/ mL packaged in 50 mg/ mL, 150 mg/ 15 mL, 450 mg/ 45 mL and 600 mg/ 60 mL Multi-dose vials. Read Full Story

Strides Arcolab receives US FDA approval for Carboplatin Injection
Mumbai, Nov 11 : Pharma major, Strides Arcolabs today said that its wholly owned subsidiary Onco Therapies Limited, has received US FDA approval for Carboplatin Injection 10 mg/ mL packaged in 50 mg/ mL, 150 mg/15 mL, 450 mg/ 45 mL and 600 mg/ 60 mL Multi-dose vials. Read Full Story

Ranbaxy reports Rs.464.6 crore net loss
Mumbai, Nov 9 : Pharmaceutical major Ranbaxy Laboratories Wednesday reported a net loss of Rs.464.6 crore for the quarter ended Sep 30. The company had posted a profit of Rs.308 crore in the like period of 2010-11. Read Full Story

Aurbobindo pharma registers net loss of Rs 80.16 cr
Mumbai, Nov 9 : Aurobindo Pharma, one of the largest Active Pharamceutical ingredients (API) manufacturers in India, has posted a net loss of Rs 80.16 crore for the quarter ended September 30, 2011 as compared to net profit of Rs 198.32 crore for the quarter ended September 30, 2010. Read Full Story

ICMR to develop affordable diabetes test strip: Azad
New Delhi, Nov 8 : The Indian Council of Medical Research (ICMR) has been tasked with developing affordable test strips for diabetes, Health Minister Ghulam Nabi Azad said Tuesday. Read Full Story

Strides Arcolab gets US regulator nod for cancer drug
New Delhi, Nov 3: Onco Therapies Ltd, a wholly-owned unit of Strides Arcolab Ltd, today announced that it has received approval from the US drug regulator for Doxorubicin Hydrochloride Injection used in the treatment of cancer. Read Full Story

Onco Therapies recieve FDA approval for Doxorubicin
Bangalore, Nov 2 : Onco Therapies Limited, a wholly owned subsidiary of Pharma major Strides Arcolab Limited (Strides) today announced that it has received US FDA approval for Doxorubicin Hydrochloride Injection, a cancer chemotherapy drug, commonly used in treatment of a wide range of cancers. Read Full Story

Party drug meow meow killing young Britons
London, Oct 27 : Party drug "meow meow" or mephedrone, used as a replacement for ecstasy or cocaine, and termed Britain's "favourite new drug" has caused nearly 100 deaths of young people in the past two years. Read Full Story

Torrent Pharma profit up in Q2
Ahmedabad, Oct 19: The city-based pharma major Torrent Pharmaceuticals Limited has achieved a net profit of Rs 100 crore during the second quarter of 2011-12, when its total revenues stood at Rs 683 crore, the company said today. Read Full Story

Trivitron invests in Kiran Medical
Kolkata, Oct 12 : Trivitron Healthcare, a leading medical technology provider, has announced the completion of a strategic investment in Kiran Medical Systems Ltd, a global leader in image enhancement and radiation protection. Read Full Story

Ranbaxy's US subsidiary bags NJBIA award
New Delhi, Oct 12 : Ranbaxy Inc, a wholly-owned subsidiary of Ranbaxy Laboratories Ltd (RIL), today said it has been honoured with the New Jersey Business Industry Association's (NJBIA) award for excellence in business expansion and eEconomic contribution to the State. Read Full Story

Aurobindo Pharma gets USFDA nod for Gabapentin tablets
New Delhi, Oct 11 : Drug firm Aurobindo Pharma today said it has received final approval from USFDA to manufacture and market generic Gabapentin tablets, used in the treatment of central nervous system (CNS) disorders. Read Full Story

Foreign investment in pharma to face competition check
New Delhi, Oct 11 : India will continue to allow 100 percent foreign direct investment in the pharmaceutical sector but the competition watchdog will keep a check on the flow of overseas funds and mergers and acquisitions in the industry, an official said. Read Full Story

Strides Arcolab gets USFDA nod for Cladribine injection
New Delhi, Oct 10 : Onco Therapies Ltd, a wholly owned subsidiary of Strides Arcolab Ltd (Strides) today announced that it has received USFDA approval for Cladribine injection used to treat a type of blood cancer known as hairy cell leukemia. Read Full Story

New pills to treat neurological diseases come closer to reality
Washington, Oct 8 : University of Notre Dame researchers have made a promising step on the road to developing new drugs for a variety of neurological diseases, by focusing on the design, synthesis and evaluation of water-soluble "gelatinase inhibitor" compounds. Read Full Story

AIOCD demands to repeal new Schedule HX in Drugs and Cosmetics Rules
Thane, Oct 6 : The All India Organisation of Chemists and Druggists (AIOCD) today demanded to repeal the recently inserted Schedule HX in the Drugs and Cosmetics Rules, 1945, saying it will adversely affect the survival of more than 7.5 lakh chemists in the country. Read Full Story

Ranbaxy to distribute Daiichi Sankyo's product in Italy
New Delhi, Oct 4 : Ranbaxy today announced that it has entered into a partnership with Japanese-drug firm Daiichi Sankyo to distribute the latter's products in Italy. Read Full Story

Strides Aecolab receives USFDA approval
Mumbai, Oct 3 : Pharma Major Strides Arcolab Limited (Strides) today announced that it has received US FDA approval for Clindamycin Injection, USP, an antibiotic used to treat bacterial infections. Read Full Story

Strides receives US approval for antibiotic injection
Mumbai, Oct 3 : Strides Arcolab Limited, a global pharmaceutical company, on Monday announced that it has received US FDA approval for Clindamycin Injection, USP, an antibiotic used to treat bacterial infections. Read Full Story

Strides Arcolab receives US FDA approval for Clindamycin injection
Bangalore, Oct 3 : Strides Arcolab Limited (Strides) today has received US FDA approval for Clindamycin Injection, USP, an antibiotic used to treat bacterial infections and to be launched early next year. Read Full Story

Onco Therapies gets US FDA nod for Paclitaxel; to launch soon
New Delhi, Sep 30 : Onco Therapies Ltd, a wholly-owned arm of Strides Arcolab Ltd (Strides), today announced that it has received US Food and Drug Administration (FDA) approval for Paclitaxel Injection USP. Read Full Story

Strides Arcolabs gets US FDA approval
Mumbai, Sept 30 : Strides Arcolabs today said its wholly owned subsidiary Onco Therapies Limited has received US FDA approval for Paclitaxel Injection USP, packaged in multiple dose vials. Read Full Story

Soon, a 'stay sober' pill that stops you from getting drunk despite a binge
London, Sept 29 : Scientists are developing a "stay sober" pill that can stop people from making fools of themselves on a night out by limiting the effects of alcohol on their brains. Read Full Story

Ind Swift gets TGA approval from Australia
Mumbai, Sept 27 : Ind-Swift Laboratories Limited, a global pharmaceutical company, on Tuesday said it has got Therapeutic Goods Administration (TGA) approval from Australia for seven of its APIs - Donepezil HCI, Clarithromycin, Letrozole, Pioglitazone HCI, Ropinirole, Acamprosate and Aripiprazole to be manufactured at its facility at Derabassi. Read Full Story

Indian takes pharmaceuticals to new heights in Ghana
By Francis Kokutse, Accra (Ghana) Sep 27 : Gopal Vasu did not leave India to be recognised in Ghana for his work in the pharmaceutical industry. However, the firm that the former oil company executive helped found has been ranked 35th in the list of Ghana's top 100 companies. Read Full Story

Suven participates at 4th CNS conference in USA
Hyderabad, Sep 22:Suven Life Sciences today announced that it was participating at 4th CNS partnering and deal making two-day onference held at San Francisco from September 22. Read Full Story

BMY drug to cure 83pc Hepatitis C patients?
New Delhi, Sept 21 : Bristol-Myers Squibb Company (NYSE: BMY), a global biopharmaceutical company, on Wednesday claimed its experimental drug BMS-790052 Plus can cure up to 83pc of Genotype 1 Hepatitis C patients. Read Full Story

Prostate cancer 'wonder' pill launched in UK
London, Sept 21 : A 'miracle' pill that can help prostate cancer patients live around five months longer has been launched in the UK, following a green signal from the European medical authorities earlier this month. Read Full Story

Lupin gets USFDA approval for its first oral contraceptive
Mumbai, Sep 20 : Pharma major, Lupin Ltd today said its subsidiary, Lupin Pharmaceuticals Inc. (LPI) has been granted final approval by the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to market a generic version of Watson's NOR-QD® tablets. Read Full Story

Fortis Healthcare to buy sister arm Fortis International
New Delhi, Sep 19: Fortis Healthcare will buy its overseas sister arm Fortis Healthcare International in an all-cash deal in a move to bring all the group's healthcare businesses under one firm, Fortis Group Chairman Malvinder Mohan Singh said Monday. Read Full Story

Fortis to consolidate its healthcare businesses under one arm
New Delhi, Sep 19 : Leading healthcare provider Fortis Monday said it has decided to bring all its healthcare businesses under one firm. Read Full Story

Jubilant in pact with US firm to manufacture women health product
New Delhi, Sep 14: Pharmaceutical firm Jubilant Life Sciences Ltd today said its subsidiary--Jubilant HollisterStier, a contract manufacturer in North America--has entered into a contract with a US firm to manufacture an over-the-counter (OTC) women health and personal care product. Read Full Story

Use of birth control pills alters memory
Washington, Sept 10 : A new UC Irvine research has found that women who use contraceptives like birth control pills experience memory changes. Read Full Story

South-East Asian countries commit to combat drug resistance
Jaipur, Sept 6 : Health Ministers from eleven South-East Asian countries adopted the Jaipur Declaration on Antimicrobial Resistance on Tuesday, committing to preserving the efficacy of antibiotics through rational use and regulation. Read Full Story

Ranbaxy launches Esomeprazole tab in UK
New Delhi, Sep 5 : Ranbaxy (UK) Ltd today announced that it has launched esomeprazole tablets, a drug used in the treatment of dyspepsia and peptic ulcer disease (PUD), in the United Kingdom (UM). Read Full Story

Ranbaxy, Daiichi to spend 200 mln yen on mobile clinics
New Delhi, Aug 31 : Pharmaceutical firm Ranbaxy today announced that the company alongwith Daiichi Sankyo will spend about 200 million yen (over Rs 10 crore) over the next five years to sponsor mobile healthcare field clinics in India, Cameroon and Tanzania. Read Full Story

Dairy giant buys Indian pharmaceutical firm
Wellington, Aug 31 : Dairy giant Fonterra has bought an Indian pharmaceutical firm as part of a joint venture with a Dutch dairy company. Read Full Story

Chinese pharma company's licence cancelled over inspection
New Delhi, Aug 30: India has cancelled the import licence granted to a Chinese pharma company after it refused to allow an Indian team to inspect the facility, Health Minister Ghulam Nabi Azad said Tuesday. Read Full Story

Venus Remedies' anti-cancer drug gets mkt authorisaton for Portuga
New Delhi, Aug 29: Pharmaceutical firm Venus Remedies today said its subsidiary--Venus Pharma GmbH, Germany--has received market authorisation for its anti-cancer product--Docetaxel--for Portugal. Read Full Story

Venus Remedies Docetexal receives MA in EUROPE
Mumbai, Aug 29 : Venus Remedies, a leading research based global pharmaceutical company, has added another feather to its cap by fetching one more Market Authorisation (MA) for its anti cancer product, Docetaxel. Read Full Story

Japanese firms eye India with pills to keep you young, healthy
By Gyanendra Kumar Keshri , New Delhi, Aug 29 : In a bid to tap the USD 1-billion nutraceutical market in India products that combine the benefits of nutrition with pharmaceuticals two Japanese firms are entering India, promising pills to help you keep you young and healthy. Read Full Story

New anticoagulant pill cuts stroke deaths by 11 pc
Washington, August 29 : A new anticoagulant drug has shown promise to reduce death rates due to strokes. Read Full Story

Aventis Pharma acquires Universal Medicare's business
Mumbai, Aug 24: Aventis Pharma Limited, part of the Sanofi Group, announced today that it has entered into a definitive agreement to acquire Universal Medicare Private Limited's business of marketing and distribution of branded nutraceutical formulations in India. Read Full Story

Lincoln Pharma launches ayurvedic product for women
Ahmedabad, Aug 17: City-based Lincoln Pharmaceuticals Ltd (LPL) today announced the launch of ayurvedic product 'ISL Granuels' to serve mother and child healthcare segment. Read Full Story

Elder Pharma posts higher net profit of Rs 20.11 cr for Q1
Dehradun Aug 17: Drug firm Elder Pharmaceuticals having two manufacturing units in Dehradun, Uttarakhand (NSE SYMBOL ELDERPHARM), has posted excellent standalone results for the first quarter ended June 2011 (Q1 FY2012). Read Full Story

Aanjaneya Lifecare announces 33 per cent rise in Total Sales
Mumbai, Aug 16: Mumbai-based Aanjaneya Lifecare Limited, a vertically integrated pharmaceutical company, has announced that the Total Sales increased by 33 per cent, from Rs 75.3 crore last year to Rs 100.24 crore in the first quarter ended June 2011 for the fiscal year 2011-2012. Read Full Story

Fortis Healthcare Q1 net slips 57.5 pc
New Delhi, Aug 12 : Fortis Healthcare (India) Ltd today said its net profit dipped by 57.5 per cent at Rs 11.74 crore for the quarter ended June 30. Read Full Story

Jubilant inks USD 80 mn contract with global firm
New Delhi, Aug 12 : Pharmaceutical company Jubilant Life Sciences Friday said that it has entered into a long term supply contract of proprietary products with an international life sciences company valued at USD 80 million. Read Full Story